LYMPHOMA, LARGE B-CELL, DIFFUSE
Clinical trials for LYMPHOMA, LARGE B-CELL, DIFFUSE explained in plain language.
Never miss a new study
Get alerted when new LYMPHOMA, LARGE B-CELL, DIFFUSE trials appear
Sign up with your email to follow new studies for LYMPHOMA, LARGE B-CELL, DIFFUSE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Less chemo, same hope: new regimen for HIV lymphoma patients
Disease control CompletedThis study tested a shorter course of chemotherapy (EPOCH-R) in 68 people with HIV and untreated CD20-positive lymphoma. The goal was to see if stopping treatment early, after the cancer disappeared, could reduce infections and future cancer risks. Results showed the approach hel…
Matched conditions: LYMPHOMA, LARGE B-CELL, DIFFUSE
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 06:17 UTC
-
New pill shows promise for hard-to-treat blood cancers in chinese patients
Disease control CompletedThis study tested an oral drug called LOXO-305 in 87 Chinese adults with chronic lymphocytic leukemia, small lymphocytic lymphoma, or non-Hodgkin lymphoma whose cancer had returned or not responded to prior treatments. The main goal was to see how many patients had their tumors s…
Matched conditions: LYMPHOMA, LARGE B-CELL, DIFFUSE
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 26, 2026 05:51 UTC
-
New vaccine strategy aims to shield lymphoma patients from deadly infections
Prevention CompletedThis study tested a two-step pneumococcal vaccine in 26 adults with diffuse large B-cell lymphoma who were receiving rituximab chemotherapy. The goal was to see if giving two different vaccines in sequence could boost protection against serious pneumococcal infections. The approa…
Matched conditions: LYMPHOMA, LARGE B-CELL, DIFFUSE
Phase: PHASE3 • Sponsor: University Hospital, Tours • Aim: Prevention
Last updated May 26, 2026 06:17 UTC
-
HIV Patients' CAR T-Cell cancer treatment under the microscope
Knowledge-focused CompletedThis study looked back at 30 people with HIV who were treated with CAR T-cell therapy for certain blood cancers like lymphoma or leukemia. Researchers collected standard medical data to see how often side effects occurred and how the immune system changed over time. The goal was …
Matched conditions: LYMPHOMA, LARGE B-CELL, DIFFUSE
Sponsor: AIDS Malignancy Consortium • Aim: Knowledge-focused
Last updated May 26, 2026 06:23 UTC